Victrelis (boceprevir) - Important Safety information from MSD as approved by the Irish Medicines Board
23 February 2012
In agreement with the European Medicines Agency (EMA), MSD would like to inform you about new information on drug-drug interaction of boceprevir, an oral hepatitis C virus (HCV) NS3/4A protease inhibitor, and ritonavir-boosted HIV protease inhibitors.
Victrelis (boceprevir) - Important Safety information from MSD